Concepedia

Peter T. Doohan

PT

Statistics

Publications

9

Citations

530

H-Index

9

Active since

2019

Affiliations

The University of Sydney(Current)

Royal Prince Alfred Hospital

UNSW Sydney

Griffith University

Woolcock Institute of Medical Research

Peter T. Doohan is an author at The University of Sydney specializing in pharmacology, cannabinoid pharmacology, and neuropharmacology.

ORCID

Publications per year

2019–2022

9

Publications

9

Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions

Lyndsey L. Anderson, Nathan L. Absalom, Sarah V. Abelev et al. · Epilepsia · 2019 · 156 citations · Full text

, , +15

Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization

Peter T. Doohan, Lachlan Oldfield, Jonathon C. Arnold et al. · The AAPS Journal · 2021 · 97 citations

, , +11

Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy

Lyndsey L. Anderson, Marika Heblinski, Nathan L. Absalom et al. · British Journal of Pharmacology · 2021 · 63 citations · Full text

, , +11

Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial

Danielle McCartney, Anastasia Suraev, Peter T. Doohan et al. · Journal of Psychopharmacology · 2022 · 50 citations · Full text

, , +14

Effects of Cannabidiol on Exercise Physiology and Bioenergetics: A Randomised Controlled Pilot Trial

Ayshe Sahinovic, Christopher Irwin, Peter T. Doohan et al. · Sports Medicine - Open · 2022 · 46 citations · Full text

, , +17

1–5 of 9